Trexquant Investment LP Uni Qure N.V. Transaction History

Trexquant Investment LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.39 - $5.43 $140,594 - $173,901	32,026 New	32,026 $143,000
Q3 2023 Nov 13, 2023	SELL	$6.71 - $11.83 $124,960 - $220,310	-18,623 Reduced 31.04%	41,377 $277,000
Q2 2023 Aug 11, 2023	BUY	$11.12 - $22.2 $667,200 - $1.33 Million	60,000 New	60,000 $687,000
Q3 2021 Nov 12, 2021	SELL	$26.01 - $38.22 $406,432 - $597,225	-15,626 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$29.97 - $37.17 $468,311 - $580,818	15,626 New	15,626 $481,000
Q1 2021 May 13, 2021	SELL	$29.24 - $42.03 $307,721 - $442,323	-10,524 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$35.35 - $50.67 $372,023 - $533,251	10,524 New	10,524 $380,000
Q2 2020 Aug 07, 2020	SELL	$45.06 - $67.74 $243,729 - $366,405	-5,409 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$40.01 - $73.97 $216,414 - $400,103	5,409 New	5,409 $257,000
Q4 2019 Feb 12, 2020	SELL	$37.13 - $74.62 $464,199 - $932,899	-12,502 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$39.36 - $76.8 $249,699 - $487,219	6,344 Added 103.02%	12,502 $492,000
Q2 2019 Aug 09, 2019	SELL	$52.76 - $82.19 $1.4 Million - $2.19 Million	-26,614 Reduced 81.21%	6,158 $481,000
Q1 2019 May 13, 2019	BUY	$27.39 - $68.41 $897,625 - $2.24 Million	32,772 New	32,772 $1.96 Million
Q3 2018 Nov 09, 2018	SELL	$29.75 - $43.08 $214,438 - $310,520	-7,208 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$21.96 - $39.94 $158,287 - $287,887	7,208 New	7,208 $272,000

154

40.4M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $712M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.